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Neil3-dependent base excision 
repair regulates lipid metabolism 
and prevents atherosclerosis in 
Apoe-deficient mice
Tonje Skarpengland1,2, Sverre Holm1, Katja Scheffler3,4,5, Ida Gregersen1,2, Tuva B. Dahl1,2,6, 
Rajikala Suganthan7, Filip M. Segers1, Ingunn Østlie8, Jeroen J. T. Otten9, Luisa Luna7, 
Daniel F. J. Ketelhuth11, Anna M. Lundberg11, Christine G. Neurauter7, Gunn Hildrestrand7, 
Mona Skjelland12, Bodil Bjørndal13, Asbjørn M. Svardal13, Per O. Iversen4,14,15, Ulf Hedin10, 
Ståle Nygård5, Ole K. Olstad16, Kirsten Krohg-Sørensen2,17, Geir Slupphaug18,19, Lars Eide2,3, 
Anna Kuśnierczyk18,19, Lasse Folkersen20, Thor Ueland1,2,6, Rolf K. Berge13,21, Göran K. Hansson11, 
Erik A. L. Biessen9, Bente Halvorsen1,2,6,*, Magnar Bjørås2,7,19,* & Pål Aukrust1,2,6,22,*
Increasing evidence suggests that oxidative DNA damage accumulates in atherosclerosis. Recently, we 
showed that a genetic variant in the human DNA repair enzyme NEIL3 was associated with increased 
risk of myocardial infarction. Here, we explored the role of Neil3/NEIL3 in atherogenesis by both clinical 
and experimental approaches. Human carotid plaques revealed increased NEIL3 mRNA expression 
which significantly correlated with mRNA levels of the macrophage marker CD68. Apoe−/−Neil3−/− mice 
on high-fat diet showed accelerated plaque formation as compared to Apoe−/− mice, reflecting an 
atherogenic lipid profile, increased hepatic triglyceride levels and attenuated macrophage cholesterol 
efflux capacity. Apoe−/−Neil3−/− mice showed marked alterations in several pathways affecting hepatic 
lipid metabolism, but no genotypic alterations in genome integrity or genome-wide accumulation 
of oxidative DNA damage. These results suggest a novel role for the DNA glycosylase Neil3 in 
atherogenesis in balancing lipid metabolism and macrophage function, potentially independently of 
genome-wide canonical base excision repair of oxidative DNA damage.
Complications of atherosclerosis, including stroke and myocardial infarction (MI), are major causes of mortal-
ity and morbidity worldwide. Atherosclerosis is acknowledged as a multifactorial disease comprising a broad 
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spectrum of interacting inflammatory and metabolic pathways1. However, all aspects of the underlying pathogen-
esis are far from clear and there is a need for delineating novel pathogenic mechanisms that could represent new 
targets for therapy in atherosclerotic disorders.
Over the past decades, oxidative stress has been widely accepted as an important feature of atherosclerosis. 
Oxidative stress induces both nuclear and mitochondrial DNA damage, and accumulation of DNA damage has 
been reported in atherosclerotic lesions2. If not counteracted, DNA damage may challenge the genomic integrity, 
leading to cellular dysfunction, senescence, mutagenesis or death3,4. Thus, DNA repair mechanisms represent 
molecular processes with a potential to influence the pathogenesis of atherosclerosis.
Base excision repair (BER) is the major pathway for removal of oxidized DNA bases5. BER is initiated by 
a lesion-specific DNA glycosylase that removes the damaged base to generate an abasic site (AP site). The 
potentially harmful AP site is further processed by various enzymatic activities, which either includes a nucle-
ase that removes the base-less sugar-phosphate residue, or a flap endonuclease/helicase for excision of larger 
DNA fragments. BER is subsequently completed by incorporation of a native base by a polymerase, and finally a 
ligase-mediated sealing of the DNA strand5. At least five different DNA glycosylases, including NEIL1, NEIL2 and 
NEIL3, with partly overlapping substrate affinities are involved in the removal of oxidized DNA bases. Moreover, 
oxidative base lesion-specific glycosylases in mammals are bifunctional and have intrinsic lyase activity, thus 
generating strand breaks rather than abasic sites. Whereas the majority of these glycosylases are ubiquitously 
expressed, murine Neil3 expression is age-dependent and restricted to discrete regions harboring proliferating 
cells, including bone marrow, spleen and cerebral niches of stem cell populations6–8. Neil3 also appears to play a 
role in regeneration after cerebral hypoxic ischemic injury9.
Studies exploring the role of DNA repair, and BER in particular, in atherosclerosis are limited. Based on 
NEIL3′ s role in repair of oxidative DNA damage and its impact on cell proliferation and regeneration following 
ischemic injury, we hypothesized that NEIL3 could play a role in diseases characterized by metabolic and oxi-
dative stress such as atherosclerosis. Here, this hypothesis was investigated by several experimental approaches, 
including examination of samples from patients with carotid atherosclerosis, studies of Neil3 deficiency in 
atherosclerosis-prone mice and in vitro experiments in relevant cell lines.
Results
Increased NEIL3 expression in human carotid plaques. We first examined if NEIL3 gene expression 
was regulated in clinical atherosclerosis by assessing transcript levels in human carotid plaques of two different 
study populations (i.e., Biobank of Karolinska Endarterectomies [BiKE] of Stockholm [Supplementary Table S1]10 
and Biobank of Oslo [Supplementary Table S2]). In BiKE, microarray analyses revealed increased NEIL3 expres-
sion in plaques (n = 106) as compared to non-atherosclerotic control arteries (n = 10, iliac arteries from organ 
donors, 3 females/7 males, median age 54 years, range 30–61 years) (Fig. 1A). These findings were replicated 
by RT-qPCR analysis of carotid plaques (n = 68) and non-atherosclerotic control arteries (n = 9, iliac arteries 
from organ donors, 2 females/7 males, median age 37 years, range 15–62 years) of the Biobank of Oslo, with 
enhanced NEIL3 mRNA levels in carotid plaques (Fig. 1B). There was no significant difference between sympto-
matic (i.e., unstable plaques, n = 54) and asymptomatic (i.e., stable plaque, n = 14) lesions, categorized according 
to presence or absence of relevant clinical symptoms within the last 6 months, suggesting that the regulation of 
NEIL3 in human carotid plaques is related to the chronic atherosclerotic process rather than to plaque destabili-
zation (Fig. 1B). Whereas the controls and patients were comparable in relation to gender, the organ donors were 
younger. Of ethical reasons it is not possible to obtain control samples from carotid arteries, and samples collected 
during autopsy will be unreliable due to degradation of mRNA. Nonetheless, difference in age between patients 
and controls is a limitation of our analyses.
The plaques from the Biobank of Oslo were further analyzed and revealed a significant positive correlation 
between mRNA levels of NEIL3 and the macrophage marker CD68 (Fig. 1C). Further, THP-1 macrophages 
exposed to lipids, i.e., VLDL and cholesterol crystals showed increased NEIL3 expression (Fig. 1D,E).
In contrast to the findings within the arterial specimens, PBMC obtained from 15 patients undergoing carotid 
endarterectomy (Biobank of Oslo) and from 16 healthy individuals showed similar NEIL3 expression (Fig. 1F), sug-
gesting that the increased expression of NEIL3 in carotid plaques is regulated within the atherosclerotic lesion rather 
than in circulating mononuclear cells. Although the “PBMC patients” were recruited from the same cohort as the 
“plaque patients”, PBMC and plaques were obtained from different patients, weakening the impact of this finding.
Increased atherosclerosis in male Apoe−/−Neil3−/− mice on high-fat diet. To elucidate the poten-
tial role of enhanced NEIL3 expression in human carotid plaques, we examined the effect of Neil3 deficiency 
in experimental atherosclerosis. Male Apoe−/−Neil3−/− and Apoe−/− mice were fed high-fat diet for 18 weeks to 
accelerate plaque formation and metabolic and oxidative stress11–15. En face quantification of atherosclerosis in 
the aortic arch revealed significantly larger lesions in Apoe−/−Neil3−/− as compared to Apoe−/− mice (Fig. 2A,B). 
Congruent with the en face results, frozen sections of the aortic root displayed increased plaque formation in 
Apoe−/−Neil3−/− mice (Fig. 2C–E), showing that Neil3 deficiency accelerates atherogenesis in male Apoe−/− mice 
on high-fat diet.
Immunohistochemistry of the aortic lesions revealed significantly higher content of Cd68+ macrophages 
and Cd4+ T cells in plaques of Apoe−/−Neil3−/− mice although not significant when adjusted for plaque sizes 
(Supplementary Figure S1A–F). However, more advanced plaques may show an increase in relative necrotic core 
area, as also seen in the Apoe−/−Neil3−/− mice (Fig. 2F), with reduced relative macrophage content, suggest-
ing that Neil3 deficiency may in fact enhance the content of lesional macrophages. No differences in Cd8+ T 
cells, Vcam1-positive endothelial cells or α -actin positive smooth muscle cells (SMCs) were detected between 
the two genotypes (Supplementary Figure S1G–O). Neither bright field microscopy nor polarized light micros-
copy, showed differences in relative collagen content between the two groups (Supplementary Figure S2). Also, 
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evaluation of the lesions with polarized light microscopy demonstrated similar levels of thick (red) and thin 
(green) collagen fibers (Supplementary Figure S2).
An atherogenic lipid profile in Apoe−/−Neil3−/− mice. Assessment of the cytokine profile in plasma 
displayed only few changes, with decreased levels of both pro- (i.e., IL-1β and G-CSF) and anti- (i.e., IL-5) ather-
ogenic cytokines in Apoe−/−Neil3−/− mice (Supplementary Table S3). However, the Neil3−/−Apoe−/− mice showed 
a markedly disturbed lipid profile in plasma/serum after 18 weeks on high-fat diet as compared to Apoe−/− mice, 
with higher levels of TG, total cholesterol, free cholesterol, LDL cholesterol, oxidized LDL (oxLDL) cholesterol 
and HDL cholesterol (Supplementary Figure S3A–F). Other metabolic parameters, such as body weight, rela-
tive fat and lean body mass, as well as food intake and glucose levels were similar between the two genotypes 
(Supplementary Table S4).
Increased levels of TG and monounsaturated fatty acids (MUFA) in the liver of Apoe−/−Neil3−/− 
mice. The increased plasma levels of TG and cholesterol could potentially be related to altered hepatic lipid 
metabolism, and measurement of liver lipids in non-fasting mice revealed elevated TG and total FA levels in the 
Apoe−/−Neil3−/− mice (Fig. 3A,B), without any significant changes in liver cholesterol and phospholipid levels 
(Supplementary Table S5). The accumulation of TG in Apoe−/−Neil3−/− mice was accompanied by accelerated 
hepatic steatosis, as assessed by histological examination of liver specimens (Fig. 3C). The increased levels of FA 
in Apoe−/−Neil3−/− mice reflected increased MUFA, mainly caused by increased levels of C18:1n-9 and C18:1n-7 
(Supplementary Table S5). In contrast, the hepatic levels of total polyunsaturated FA (PUFA) were decreased 
in Apoe−/−Neil3−/− mice, reflecting a significant reduction of n-9 PUFA and n-6 PUFA, including a decrease in 
C20:4n-6 (arachidonic acid) (Supplementary Table S5). Although n-3 PUFA levels were similar, C20:5n-3 (eicos-
apentaenoic acid), which has shown anti-atherogenic properties, was significantly reduced in Apoe−/−Neil3−/− 
(Supplementary Table S5). Our findings suggest that the liver of Apoe−/−Neil3−/− mice accumulates TG and FA, 
with an increase in MUFA and a decrease in PUFA, reflecting a pro-atherogenic lipid profile16.
The increased TG levels could be caused by decreased hepatic FA processing via β -oxidation. However, the 
activities of the mitochondrial enzymes performing β -oxidation, i.e., carnitine palmitoyltransferase-1 (Cpt-1) 
and Cpt-2, were significantly enhanced in the Apoe−/−Neil3−/− mice (Fig. 3D,E), and the Cpt-1 activity remained 
Figure 1. Regulation of NEIL3 in clinical carotid atherosclerosis. (A) Relative NEIL3 expression in human 
control arteries (n = 10) and carotid atherosclerotic plaques (n = 106) from the Biobank of Karolinska 
Endarterectomies (BiKE), as evaluated by microarray. (B) Relative NEIL3 expression in human control arteries 
(n = 9) as well as in asymptomatic (n = 14) and symptomatic (n = 54) carotid plaques from the Biobank of Oslo, 
as evaluated by RT-qPCR. (C) The correlation between mRNA levels of NEIL3 and CD68 in carotid plaques 
(n = 67, Biobank of Oslo). (D) NEIL3 expression in THP-1 macrophages that were exposed to VLDL (25 μ g/ml)  
and (E) cholesterol crystals (100 μ g/ml) for 6 hours (n = 5–6). (F) Relative NEIL3 expression in PBMC 
isolated from healthy controls (n = 16) and patients with ischemic stroke (n = 15). mRNA levels in (B–F) 
were quantified by RT-qPCR and normalized to β-ACTIN. Experiments in (D,E) were repeated twice with 
similar findings. Data are presented as single values, median and interquartile range. * p < 0.05, * * p < 0.01, 
***p < 0.001 and * * * * p < 0.0001.
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higher also in the presence of its natural key inhibitor malonyl-CoA (Fig. 4F). Altogether, these results suggest 
enhanced rather than decreased β -oxidation of long-chain FA in the Apoe−/−Neil3−/− mice, but assessment of 
plasma carnitine metabolites revealed higher levels in the Apoe−/−Neil3−/− mice of both palmitoyl-carnitine 
and the end product of β -oxidation, acetyl-carnitine (Supplementary Table S6), indicating that the increase in 
β -oxidation was unable to reduce the elevated TG levels. Moreover, the FA producing enzymes FA synthase (Fasn), 
glycerol-3-phosphate acyltransferase (Gpat) and acetyl-CoA carboxylase (Acc) all showed similar activities in both 
genotypes (Fig. 3G–I). Since there were no genotypic differences in relative body fat distribution or plasma free 
FA (Supplementary Table S4 and Table S6, respectively), the differences in TG levels were seemingly not induced 
by augmented FA release from peripheral fat tissues. In summary, elevated hepatic TG levels in Apoe−/−Neil3−/− 
mice appeared not to be caused by decreased FA β -oxidation, augmented FA release from peripheral fat tissues or 
Figure 2. Neil3 deficiency on an Apoe−/− background augments atherosclerosis in male mice fed a high-fat 
diet. (A) Representative en face images of the aortic arch stained with Sudan IV. (B) Data show en face % lesion 
area of Apoe−/− (n = 11) and Apoe−/−Neil3−/− (n = 9) mice. (C) Representative cryosections (10 μ m) of the aortic 
root, stained with Oil Red O and hematoxylin. Original magnification 40X. (D) Relative lesion areas (lesion 
area/area inside external elastic lamina × 100) in cross-sections of the aortic root, calculated from 8 consecutive 
sections per mouse at 100 μ m intervals in Apoe−/− (n = 9) and Apoe−/−Neil3−/− (n = 10) mice. (E) The graph 
shows the mean and SEM of relative lesion areas at 8 different positions in the aortic root; n = 9–11 (Apoe−/−) 
and n = 10 (Apoe−/−Neil3−/−), respectively. * p < 0.05 and * * p < 0.01 versus Apoe−/− mice. (F) Necrotic core area 
as percentage of total plaque area in Apoe−/− (n = 10) and Apoe−/−Neil3−/− (n = 10) mice. Data in (B,D,F) are 
presented as single values, median and interquartile range and were analyzed using Mann-Whitney U test.
www.nature.com/scientificreports/
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increased hepatic FA synthesis. Since hepatic MUFA and total FA levels were elevated, our data suggest that the 
increase in TG reflect enhanced substrate availability for TG synthesis rather than altered enzyme activity.
Marked alterations in hepatic pathways involved in lipid metabolism in Apoe−/−Neil3−/− 
mice. In order to assess the general impact of Neil3 deficiency on all genes involved in liver metabolism, 
mRNA sequencing analysis was executed. In total, 495 and 209 hepatic genes were upregulated and downregu-
lated in Apoe−/−Neil3−/− mice, respectively, suggesting that Neil3 deficiency has a significant impact on hepatic 
gene expression (Fig. 4A). KEGG pathway enrichment analysis revealed that among the top 15 pathways sig-
nificantly enriched in differently expressed genes (DEGs), several were involved in lipid metabolism (i.e., the 
Figure 3. Increased hepatic lipids in Apoe−/−Neil3−/− mice. Hepatic levels of (A) TG and (B) FA.  
(C) Representative images of liver histology of paraffin sections stained with hematoxylin and eosin. Panels 
(D–I) show the activity of hepatic enzymes involved in TG metabolism: Carnitine palmitoyltransferase-1  
(Cpt-1), Cpt-2, Cpt-1 + malonyl, FA synthase (Fasn), glycerol-3-phosphate acyltransferase (Gpat) and  
acetyl-CoA carboxylase (Acc). Data are presented as single values, median and interquartile range.
www.nature.com/scientificreports/
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arachidonic acid pathways, metabolism of xenobiotics, PPAR-related pathways, metabolic pathways, steroid hor-
mone biosynthesis pathways, pathways related to bile secretion and pathways related to synthesis of unsaturated 
FA) (Fig. 4B). In summary, the atherogenic plasma lipid profile in the Apoe−/−Neil3−/− mice could be related to 
increased hepatic levels of TG, total FA and MUFA, which were congruent with the RNA sequencing data of 
marked changes in several pathways related to hepatic lipid metabolism of Apoe−/−Neil3−/− mice.
Increased lipid-induced proliferation in Apoe−/−Neil3−/− macrophages. RNA sequencing anal-
ysis revealed higher levels of aortic Cd68 (log2 = 1.19, FDR = 2.49e-278) and immunohistochemistry showed 
increased absolute number of Cd68+ cells in the aortic root of Apoe−/−Neil3−/− mice (Supplementary Figure S1). 
Gene enrichment analyses of DEGs from thoracic aorta as identified by RNA sequencing revealed a pheno-
type associated with abnormal lipid homeostasis, a transcriptional profile similar to myeloid progenitors that 
differentiate into macrophages, and a macrophage-enriched metabolic network in the Apoe−/−Neil3−/− mice 
(Supplementary Table S7). These findings suggest that macrophage-induced dysregulation of lipid homeosta-
sis within the lesion could be of importance for the more advanced plaque in the Apoe−/−Neil3−/− mice. The 
accumulation of macrophages within the lesion could reflect enhanced proliferative or migratory properties of 
Apoe−/−Neil3−/− macrophages during plaque development. To mimic the lipid challenge of plaque macrophages, 
bone marrow-derived macrophages (BMDM) from both genotypes were stimulated with VLDL and oxLDL. As 
evaluated by RT-qPCR, Ki67, as a marker of cell proliferation, in BMDM from Apoe−/−Neil3−/− mice but not from 
Apoe−/− mice, showed enhanced expression after VLDL and oxLDL stimulation as compared to unstimulated 
cells (Supplementary Figure S4A). In contrast, no differences in the number of recruited peritoneal macrophages 
were detected after induction of sterile peritonitis with thioglyollate (Supplementary Figure S4B).
We could not detect any differences between the two genotypes in bone marrow long-term hematopoietic 
stem cells and multipotent progenitor cells (Supplementary Figure S5) and immunophenotypic screening by flow 
cytometry of lymph nodes, spleen and blood did not reveal any genotypic differences in absolute cell counts or leu-
kocyte subsets (Supplementary Table S8). These results indicate that the increased number of plaque macrophages 
in Apoe−/−Neil3−/− mice may involve genotypic cell-specific differences in proliferation in response to modified 
lipids within the lesion, and not altered recruitment from hematopoietic tissues or altered chemotactic properties.
Reduced cholesterol efflux capacity in Apoe−/−Neil3−/− mice. In addition to lipid availability, the 
accumulation of lipid within the atherosclerotic lesion depends on lipid uptake and efflux capacity of lesional 
macrophages17. The cholesterol efflux capacity of BMDM of Apoe−/−Neil3−/− mice was significantly decreased 
as compared to Apoe−/− BMDM, using serum from pooled C57BL/6 wild type mice as cholesterol acceptor 
(Fig. 5A). Transcriptional assessment of the major actors of lipid efflux revealed decreased expression of Abcg1, 
Figure 4. Neil3 deficiency modulates expression of hepatic genes. (A) The numbers of genes that were 
significantly up- and downregulated in Apoe−/−Neil3−/− as compared to Apoe−/− mice by RNA sequencing 
analysis. (B) KEGG pathway enrichment analyses showing the top 15 pathways significantly enriched in 
differentially expressed genes (DEGs). Percentages were calculated based on the total number of genes (n = 570) 
with pathway annotations. Q values are FDR-adjusted p-values and a Q value < 0.05 was considered as significant. 
RNA sequencing was performed on pooled RNA from the liver of 7 Apoe−/− and 9 Apoe−/−Neil3−/− mice.
www.nature.com/scientificreports/
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Figure 5. Decreased cholesterol efflux capacity in bone marrow-derived macrophages (BMDM) from 
Apoe−/−Neil3−/− mice. (A) Cholesterol efflux capacity of BMDM from Apoe−/− (n = 7) and Apoe−/−Neil3−/− 
(n = 6) mice, using pooled serum from C57BL/6 wild type mice (n = 4) as cholesterol acceptor. The experiment 
was repeated twice with similar findings. (B,C) mRNA levels of genes involved in cholesterol efflux mechanisms; 
(n = 6-7 [Abca7, Srb1 and Nr1h3] and n = 16–17 [Abcg1]). (D) BMBM were exposed to oxLDL (20 μ g/ml) 
and 14C-cholesterol (0.5 μ Ci/ml) for 48 hours, washed with serum-free medium containing 0.2% BSA and 
the cells were lysed with 0.2 M NaOH. BMDM loading capacity was calculated as disintegrations per minute 
(dpm) per total protein. Values represent fractional (%) cholesterol efflux calculated as dpm (media)/dpm 
(media + cell-associated)] × 100. (E) mRNA levels of scavenger receptors in BMDM from Apoe−/− (n = 6) and 
Apoe−/−Neil3−/− (n = 3) mice. (F) Serum cholesterol acceptor capacity was evaluated by measuring cholesterol 
efflux from murine macrophages (RAW264.7 cells) using sera from Apoe−/− (n = 7) and Apoe−/−Neil3−/− (n = 6) 
mice as cholesterol acceptors. (G) The distribution of small plasma HDL cholesterol relative to all plasma HDL 
cholesterol. mRNA levels were quantified with RT-qPCR and normalized to β -actin as reference gene. Data are 
presented as single values, median and interquartile range. * p < 0.05.
www.nature.com/scientificreports/
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Figure 6. Similar levels of DNA damage but mtDNA copy number analysis and RNA sequencing suggest 
a reduction in lesional mitochondrial activity in Apoe−/−Neil3−/− mice. (A) Relative nuclear DNA damage 
and (B) relative mitochondrial DNA damage as evaluated by a qPCR-based method in liver (n = 7–9), aorta 
(n = 5–7) and plaques (n = 6–7). Values are normalized to nuclear and mitochondrial DNA damage in Apoe−/− 
mice, respectively. (C,D) Accumulation of 8-oxodG and 5-OHdC in liver (n = 6–9) and aortas (n = 3–4), as 
evaluated by mass spectrometry. (E) Relative DNA damage level of promoter regions from Lcn2, Ucp1 and Lpl 
as evaluated by a qPCR-based method in liver (n = 8–9). Values are normalized to promoter DNA damage level 
www.nature.com/scientificreports/
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Abca7 and Scarb1 (i.e., the murine ortholog of SR-B1) in BMDM from Apoe−/−Neil3−/− mice (Fig. 5B). Finally, the 
murine ortholog of LXRα , i.e., Nr1h3, an important regulator of cholesterol and FA homeostasis including effects 
on ABC transporters in macrophages18, influencing cholesterol efflux capacity, showed decreased mRNA expres-
sion in BMDM of Apoe−/−Neil3−/− mice (Fig. 5C). In contrast, the BMDM cholesterol loading capacity (Fig. 5D), 
the expression of the scavenger receptors Olr1 and Msr1 (i.e., orthologs of human LOX-1 and SR-A1) were similar, 
while Cd36 was decreased in Apoe−/−Neil3−/− mice (Fig. 5E). In addition to an unfavorable lipid profile, these data 
suggest that the accelerated atherogenesis in Apoe−/−Neil3−/− mice could be explained by decreased macrophage 
cholesterol efflux capacity potentially reflecting alteration in ABC transporters and Nr1h3 expression.
Serum from Apoe−/−Neil3−/− mice shows no alteration in cholesterol acceptor capacity. The 
cholesterol acceptor capacity of serum, a surrogate measure of HDL function was examined in both genotypes 
by loading mouse macrophages (RAW 264.7 cells) with oxLDL and 14C-cholesterol, before incubating these cells 
with serum from both genotypes. Measurement of the fractional efflux of 14C-cholesterol from macrophages 
revealed similar cholesterol acceptor capacities in the two genotypes (Fig. 5F). Congruent with these results, 
Lipoprint analysis showed no difference in the lipoprotein subfraction of small HDL particles (Fig. 5G), being the 
most efficient mediators of cholesterol efflux19. Thus, in contrast to the cholesterol efflux capacity in macrophages, 
the ability of HDL to “accept” cholesterol from macrophages seems not to be impaired in Apoe−/−Neil3−/− mice.
No change in genome integrity and accumulation of oxidative DNA damage in Apoe−/−Neil3−/− 
mice. The increased lipid accumulation within the plaques of Apoe−/−Neil3−/− mice could potentially induce 
accumulation of DNA damage within the atherosclerotic lesions20. Since Neil3 is acknowledged as a DNA repair 
enzyme that removes oxidative base lesions21, we examined if Neil3 deficiency could impair genome integrity 
or increase bulk accumulation of oxidative DNA base lesions within the plaques of the brachiocephalic artery 
(BCA) as well as in aorta and liver. A qPCR-based method was used for assessment of nuclear and mitochon-
drial (mt) DNA integrity, while the bulk level of oxidized DNA base lesions (8-oxoguanine [8-oxodG] and 
5-hydroxycytosine [5-OHdC]), including both nuclear and mitochondrial lesions, were measured using mass 
spectrometry. Surprisingly, none of the examined tissues showed any genotypic differences in nuclear (Fig. 6A) 
or mitochondrial (Fig. 6B) genome integrity or bulk accumulation of oxidative DNA damage (Fig. 6C,D), of 
which 5-OHdC is a substrate for Neil321. DNA damage accumulating at gene-regulatory regions (e.g., promoters) 
can alter gene expression22, and the global level of oxidative base lesions may mask accumulation of DNA base 
modifications at promoter regions in Apoe−/−Neil3−/− mice. The hepatic genes Lcn2, Ucp1 and Lpl that were 
(i) differentially regulated between the two genotypes and (ii) involved in lipid metabolism (RNA sequencing) 
were selected for quantitation of promoter DNA damage level using a qPCR-based method. We found no signif-
icant differences in the promoter DNA damage levels of Apoe−/−Neil3−/− relative to Apoe−/− mice for any of the 
selected genes (Fig. 6E). However, DNA base modifications important for gene regulation may occur outside 
of the examined gene-region. In contrast to the lack of changes in oxidative DNA damage in the nucleus, the 
atherosclerotic plaques of the BCA, but not the non-atherosclerotic thoracic aorta and the liver, showed reduced 
mitochondrial copy number in Apoe−/−Neil3−/− mice as compared to Apoe−/− (Fig. 6F).
Altered expression of mitochondrial biogenesis genes in Apoe−/−Neil3−/− mice. To examine 
differences in the aortic transcriptome between Apoe−/−Neil3−/− and Apoe−/− we performed RNA sequencing. 
This analysis demonstrated that genes involved in the mitochondrial tricarboxylic acid cycle (TCA) pathway 
and oxidative phosphorylation clearly was downregulated in Neil3 deficient mice (Fig. 6G). Also, gene ontol-
ogy enrichment analyses of aortic DEGs revealed a significant overrepresentation of genes associated with the 
mitochondrial compartments in Apoe−/−Neil3−/− mice (Fig. 6H). Thus, the accelerated atherogenesis in the 
Apoe−/−Neil3−/− mice appeared not to be associated with impaired plaque DNA stability, but with alterations in 
mitochondrial functions in the macroscopically non-atherosclerotic thoracic aorta and reduced mitochondrial 
copy numbers in the atherosclerotic BCA.
Neil3 deficiency alone shows no effects on lipid parameters in serum. Finally, we examined if 
Apoe deficiency is required for the involvement of Neil3 in lipid metabolism by analyzing fasting serum lipid pro-
file in wild type (Wt) and Neil3−/− mice fed a high-fat diet for 14 weeks. As shown in Supplemental Fig. S6, serum 
TG and total cholesterol showed no differences between Wt and Neil3-deficient mice, and in general, mice on an 
Apoe−/− background had higher levels of these lipid parameters and in particular Apoe−/−Neil3−/− mice. Thus, 
it seems that the effect of Neil3 deficiency, at least for the serum lipid profile, is dependent on an environment 
characterized by high lipid levels and metabolic stress as in an Apoe-deficient phenotype.
Discussion
Based on biochemical characterization, NEIL3/Neil3 is acknowledged as a DNA repair enzyme initiating repair of 
oxidized DNA base lesions21. Recent reports have also indicated a role of NEIL3/Neil3 in maintenance of cerebral 
in Apoe−/− mice. (F) MtDNA copy number in liver (n = 7–9), aorta (n = 5–7) and plaques (n = 6–7) relative to 
the mtDNA levels in respective tissues of Apoe−/− mice. In (C,D), aortic data are presented as mean ± SEM and 
were analyzed using Students’s t test. All other data in (A–F) are presented as median and interquartile range 
and were analyzed using Mann-Whitney U test; * * p < 0.01. (G) Mitochondrial pathways significantly enriched 
in differentially expressed genes (DEGs) in aorta of Apoe−/− and Apoe−/−Neil3−/− mice, as evaluated by RNA 
sequencing. (H) Gene ontology (GO) enrichment analyses of DEGs showing an overrepresentation of genes 
associated with mitochondrial compartments in Apoe−/−Neil3−/− as compared to Apoe−/− mice.
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stem and progenitor cells by counteracting oxidative stress-induced DNA damage7,9. The biological function(s) 
of NEIL3/Neil3 are, however, still elusive. Here, we examined the role of murine Neil3 in mice prone to develop 
atherosclerosis. When challenged with a high-fat diet, male Apoe−/−Neil3−/− mice displayed increased athero-
sclerosis as compared to Apoe−/− controls, resulting from an unfavorable lipid profile including increased hepatic 
TG levels and reduced macrophage cholesterol efflux capacity (Fig. 7). The different phenotypes were not related 
to altered genomic stability or global accumulation of oxidized DNA damage, and although we have no firm evi-
dence, it is tempting to hypothesize a role for Neil3 beyond genome-wide canonical repair.
Increasing evidence supports that DNA glycosylases are involved in regulating energy metabolism. Recently, 
Ogg1-deficient mice fed high-fat diet displayed increased adiposity and hepatic steatosis23. Also, Neil1-deficient 
mice developed severe obesity, fatty liver disease and dyslipidemia24. Here, we show that Neil3 influences lipid 
metabolism on an Apoe-deficient, but not on a Wt background. The Apoe−/−Neil3−/− mice showed increased 
plasma levels of TG, LDL-cholesterol and oxLDL and accelerated hepatic steatosis with increased TG accumu-
lation and altered hepatic FA distribution. Also, mRNA sequencing showed marked alterations in livers from 
Apoe−/−Neil3−/− mice, affecting several pathways involved in lipid metabolism, with increased FA/MUFA-driven 
TG synthesis as a potential mechanism for the accumulation of TG in liver and plasma. Indeed, endogenously 
Figure 7. Neil3 deficiency promotes atherosclerosis in Apoe−/− mice on a high-fat diet through effects 
on lipid metabolism and macrophages, potentially involving non-canonical effects. Neil3−/−Apoe−/− 
mice show enhanced liver steatosis with increased TG levels, potentially caused by increased substrate 
availability (MUFA). Transcriptome analysis revealed marked alterations in hepatic pathways involved in lipid 
metabolism. The hepatic accumulation of lipids in Apoe−/−Neil3−/− mice results in a hyperlipidemic plasma 
profile with subsequent enhanced atherosclerosis. Within the atherosclerotic lesion there is an accumulation 
of macrophages indicating increased lesional proliferation. The macrophages in Neil3−/−Apoe−/−mice show 
attenuated cholesterol efflux capacity, further enhancing the metabolic stress within the plaque, contributing to 
altered mitochondrial biogenesis. The authors wish to acknowledge SERVIER Medical Art (www.servier.fr) for 
use of their medical art kits when making the illustration.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:28337 | DOI: 10.1038/srep28337
synthesized MUFA are suggested to serve as main substrates for the synthesis of TG and cholesterol esters25. Also, 
C18:1n-9 level, which constitutes one of the preferred substrates for enzymes responsible for TG and cholesteryl 
ester synthesis26, was increased in the liver from the Apoe−/−Neil3−/− mice. The hepatic lipid accumulation in 
Apoe−/−Neil3−/− mice, however, could also involve other mechanisms such as altered uptake and secretion of 
FA27. Also, whether the hepatic changes are directly related to Neil3 deficiency with effects at specific gene regu-
latory regions, or if they rather involve indirect effects via e.g. FA-dependent regulation of hepatic transcription 
factors28, is presently not known.
Our finding of accelerated atherogenesis in Apoe−/−Neil3−/− mice was accompanied by enhanced aortic Cd68 
expression and increased absolute number of plaque macrophages. RNA sequencing of thoracic aorta further 
suggested a role for macrophage/lipid interaction in the accelerated atherosclerosis in the Apoe−/−Neil3−/− mice. 
Indeed, macrophages from Apoe−/−Neil3−/− mice displayed an increased proliferative response upon stimulation 
with modified lipids, potentially contributing to increased plaque accumulation of macrophages. We have previ-
ously reported that Neil3-deficient mice show reduced proliferation of neural stem progenitor cells after cerebral 
hypoxic ischemia9. Our findings herein could suggest tissue- and stressor-specific influences of the interaction 
between Neil3 and cell proliferation. Moreover, Neil3 deficiency reduced the cholesterol efflux capacity of mac-
rophages by downregulating ABC transporters. Thus, in addition to an unfavorable lipid profile and an increased 
lipid-induced macrophage proliferation, an attenuated cholesterol efflux in plaque macrophages may have con-
tributed to accelerated atherogenesis in Apoe−/−Neil3−/− mice.
Neil3 shows overlapping substrate specificity with the DNA glycosylases Neil1, Neil2 and Nth1. Despite these 
backup activities, our results indicate that Neil3 is indispensable to avoid increased atherosclerosis in mice on 
an Apoe−/− background. Several studies have showed that the substrate specificity of DNA glycosylases is not 
only dependent on the nucleobase sequence, but also on DNA structure. Wallace and coworkers demonstrated 
that NEIL3, but not NEIL1, NEIL2, NTH1 or OGG1 can remove thymine glycol in quadruplex DNA in vitro29. 
NEIL1, NEIL2 and NEIL3 are also shown to remove oxidized guanine lesions from quadruplex DNA struc-
tures formed by promoter and telomere sequences30,31. Altogether, growing evidence suggests that NEIL gly-
cosylases may have gene regulatory functions. Thus, it is plausible that the atherogenic lipid profile observed 
in the Apoe−/−Neil3−/− mice could be caused by deficient Neil3 activity at promoters regulating TG and cho-
lesterol metabolism. Assessment of genome integrity and total genome-wide oxidative DNA base damage by 
mass spectrometry showed no genotypic differences in the examined tissues relevant for lipid metabolism and 
atherogenesis. However, a Neil3-dependent accumulation of oxidative base lesions in Apoe−/−Neil3−/− mice at 
certain promoter regions, beyond those that were examined in the present study, will most likely be masked by the 
bulk levels of oxidative base lesions measured by mass spectrometry. Thus, the effects of Neil3 deficiency in our 
Apoe-deficient model on high-fat diet, characterized by lipid and metabolic stress, could still involve induction 
of oxidative base lesions. In order to further address these issues, we need methods detecting oxidative lesions at 
single base resolution.
Epigenetic DNA methylation represents a major mechanism to regulate gene expression, in which DNA meth-
yltransferases methylate cytosine at the 5-carbon position to generate 5-methyl cytosine (5-mC). Active demeth-
ylation of 5-mC involves numerous enzymes, including ten-eleven translocation enzymes and the thymine DNA 
glycosylase32. Several reports show that epigenetic DNA methylation is associated with plasma lipid concentra-
tions and increased cardiovascular risk33–35. Recently, Vermeulen and coworkers showed that several DNA gly-
cosylases, including Neil3, are epigenetic readers of oxidized derivatives of 5-mC36. Based on the findings in the 
present study, a possible role of Neil3 in active demethylation of 5-mC in promoters regulating lipid metabolism, 
should be explored in future experiments.
Genes involved in the mitochondrial TCA cycle pathway and oxidative phosphorylation were downregulated 
in non-atherosclerotic aortic tissue of Apoe−/−Neil3−/− mice, suggesting that decreased mitochondrial function 
could be an early feature of atherogenesis in this genotype. This feature was further supported by the reduced 
plaque mtDNA copy number. Recently, another study has suggested a crucial role of damaged mitochondria in 
atherogenesis, linking impaired mitochondrial function and reduced oxidative phosphorylation to increased ath-
erogenesis in Polg−/−Apoe−/− mice37. In support of the nuclear location of Neil338, the mitochondria-related genes 
investigated in our study as well as known regulators of mtDNA copy number, are all encoded by nuclear DNA39, 
suggesting that our observed alteration in plaque mtDNA copy number most probably reflects indirect effects of 
Neil3 deficiency, such as metabolic or oxidative stress within the plaque (Fig. 7).
We have recently shown that a certain genetic variant in NEIL3 (i.e., NEIL3 rs12645561; TT genotype) was 
associated with increased risk of MI40. Herein, we report marked upregulation of NEIL3 expression in carotid 
atherosclerosis as compared to non-atherosclerotic vessels in two separate cohorts. In the Oslo cohort, we found 
a significant positive correlation between plaque expression of NEIL3 and the macrophage marker CD68, and 
modified lipids enhanced the NEIL3 expression of in macrophages. Finally, PBMC from patients with carotid 
atherosclerosis did not show increased NEIL3 expression, suggesting that NEIL3 is upregulated in macrophages 
within the atherosclerotic lesion as a response to lipid exposure. Taken into account our findings in the experi-
mental models, we hypothesize that lipid-induced upregulation of NEIL3 within plaques could represent a coun-
teracting response to unfavorable lipid profiles and metabolic stress in patients with atherosclerotic disorders. 
Hence, studies in a mouse model overexpressing Neil3 may provide valuable insight into the role of Neil3 in 
human atherosclerosis.
In summary, our results reveal a novel role for murine Neil3 in balancing lipid metabolism that involves 
effects on hepatic lipid metabolism as well as cholesterol efflux capacity in macrophages, resulting in acceler-
ated atherosclerosis in Neil3 deficient mice on an Apoe−/− background (Fig. 7). We propose that Neil3/NEIL3 
could be involved in regulation of transcriptional network(s) responding to lipid stress via removal of oxidative 
lesions at gene-specific sequences of importance for promoter activity and that this also could involve activation 
of non-canonical pathways.
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Experimental Procedure
An expanded version of the Experimental Procedure section is available in the Online Data Supplementary 
section.
Ethics. The BiKE study was performed after approval by the Ethical Committee of Northern Stockholm (file 
numbers 02/147 and 2009/295-31/2) and was in compliance with institutional guidelines. Establishment and 
handling of the Oslo Biobank were approved by the Regional Committee for Medical and Health Research Ethics 
for South-East Norway (project number 6.2009.549, ref.no 2009/5237, 2009/613, 2014/2078, and ref.no S-06172). 
Both the BiKE study and the Oslo Biobank protocols were in agreement with the principles of the Declaration of 
Helsinki and signed informed consent was obtained from all individuals. The murine studies were according to 
Norwegian law regulating animal experiments and international treaties ratified by Norway. All experiments were 
approved by the Norwegian Animal Research Committee.
Human subjects and tissue sampling from human subjects. BiKE (Biobank of Karolinska 
Endarterectomies) provided human samples for microarray experiments. Briefly, endarterectomy specimens 
from the carotid artery (n = 106) were collected from patients diagnosed with > 70% carotid artery stenosis 
at Department of Vascular Surgery of the Karolinska Hospital from 2001 to 2008 (Supplementary Table S1). 
Aortic and iliac non-atherosclerotic arteries obtained from organ donors (n = 10) were used as negative controls. 
The samples from the Biobank of Oslo consisted of carotid plaques obtained from patients with internal carotid 
artery stenosis (≥ 70%) undergoing carotid endarterectomy (n = 68) at Oslo University Hospital Rikshospitalet 
(Supplementary Table S2). Iliac non-atherosclerotic arteries obtained from organ donors (n = 9) were used as 
negative controls.
Animals. Neil3-deficient mice were generated by germline deletion of exons 3–5 and backcrossed into 
C57BL/6 mice for 10 generations. Apoe−/−Neil3−/− mice were generated by crossing Neil3−/− mice with Apoe−/− 
(C57BL/6 background) mice, obtained from Taconic. The mice were fed high-fat diet (R638, Lantmännen, 
Sweden; 21% fat by weight [62.9% saturated, 33.9% unsaturated and 3.4% polyunsaturated], 17.2% protein, 43% 
carbohydrates and 0.15% cholesterol) ad libitum from 8 weeks of age until harvesting at 26 weeks of age. 
Statistical analysis. Except for the RNA sequencing analysis and experiments with a total sample size of n ≤ 7, 
all data were analyzed using non-parametric tests, i.e., the Mann–Whitney U test, Spearman’s rank correlation or 
Kruskal-Wallis test with Dunn’s post test for multiple comparisons. Experiments with a total sample size of n ≤ 7 
were analyzed using two-tailed unpaired Student’s t test and categorical data were analyzed using the chi-square 
test. Data are presented as median and interquartile range unless otherwise stated. P values < 0.05 were consid-
ered statistically significant.
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